确切的处方模式在ALS诊断前几年出现:一项全国性的基于注册表的研究
Magne Haugland Solheim1,2, Trond Riise2, Marianna Cortese3
1Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Annals of neurology
|March 11, 2026
概括
处方药模式的变化,包括肌肉松剂和骨疾病治疗,在被诊断为肌缩性侧面硬化症 (ALS) 诊断前长达六年被观察到. 这表明ALS的长期前进阶段,可以通过药物使用分析检测到.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 肌缩侧面硬化症 (ALS) 的前阶段仍然定义不完善.
- 识别早期标志物对于了解疾病进展和潜在干预措施至关重要.
研究的目的:
- 描述ALS诊断前期处方药的使用模式.
- 为了确定患有ALS和健康对照人群之间药物使用的最早分歧.
- 使用处方数据估计ALS预现象的发病和持续时间.
主要方法:
- 一个嵌套的病例控制研究,利用全国性的挪威注册 (2005-2019).
- 根据性别,年龄和教育情况,2,084例ALS病例与208,400例对照病例的个体匹配.
- 药物处方数据分析至诊断前10年,包括滞后时间分析和机器学习预测.
主要成果:
- 在ALS诊断前2-3年,总体处方模式的变化是明显的.
- 在42种药物类别中的25种中,在ALS患者和对照人群之间观察到显著的差异.
- 肌肉松剂和骨疾病治疗的处方率分别在诊断前6年和5年显著增加.
结论:
- 处方模式的变化,特别是肌肉松剂和骨疾病治疗,可以在ALS诊断前6年就发生.
- 这些发现支持在ALS临床表现之前存在多年的前性阶段.
- 在诊断前的最后一年增加的药物使用可能反映出对新出现的症状寻求更高的医疗保健.
相关概念视频
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
783
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
783
Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
Drug Therapy
361
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
361
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
320
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
320


